Mateusz Matyja
Research Subjects
Mateusz Matyja has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Anna Mazur
Medical University of Silesia
7 shared publications - Julia Brodziak
Medical University of Silesia
7 shared publications - Marta Kowalska
Medical University of Silesia
7 shared publications - Michał Dworak
Medical University of Silesia
7 shared publications - Tomasz Wiśniewski
Medical University of Silesia
7 shared publications - Wiktoria Ciszewska
Medical University of Silesia
7 shared publications
Latest Publications
- Open Access
- 15 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 88
Dietary Patterns and Supplementation in Depression and Anxiety: A Comprehensive Literature Review
Introduction and purpose: Depression and anxiety frequently co-occur and cause substantial functional burden. Nutrition - especially diet quality and supplementation - has been studied as a modifiable factor. This comprehensive literature review summarised evidence on dietary patterns and selected supplements in relation to depressive and anxiety symptoms. Material and methods: A narrative synthesis was performed using 32 articles (systematic reviews/meta-analyses, randomised trials, observational and mechanistic papers). The scope covered diet quality and dietary patterns, whole-of-diet interventions, gut–brain axis concepts, and supplementation with omega-3 fatty acids, B vitamins, magnesium, vitamin D, zinc, and probiotics. Results: Prospective evidence generally linked higher diet quality with lower depression risk. Whole-diet intervention trials showed mixed results, with several studies reporting improvements in depressive outcomes; anxiety outcomes were less consistent. Mechanistic literature supports plausibility through inflammation/oxidative pathways, serotonergic neurotransmission, and diet–microbiota interactions. Among supplements, evidence is most developed for omega-3 fatty acids (dose-response signals for anxiety) and magnesium (benefits in trials and meta-analysis), while findings for vitamin D, B vitamins, zinc and probiotics vary across studies. Conclusions: Diet quality improvement and selected supplements may offer adjunctive benefits for some individuals, but effects are heterogeneous and should not be overgeneralised. Nutritional strategies should be integrated with evidence-based mental health care, with timely clinical assessment and standard treatments used when indicated.
- 15 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 88
Open AccessDietary Patterns and Supplementation in Depression and Anxiety: A Comprehensive Literature Review
Introduction and purpose: Depression and anxiety frequently co-occur and cause substantial functional burden. Nutrition - especially diet quality and supplementation - has been studied as a modifiable factor. This comprehensive literature review summarised evidence on dietary patterns and selected supplements in relation to depressive and anxiety symptoms. Material and methods: A narrative synthesis was performed using 32 articles (systematic reviews/meta-analyses, randomised trials, observational and mechanistic papers). The scope covered diet quality and dietary patterns, whole-of-diet interventions, gut–brain axis concepts, and supplementation with omega-3 fatty acids, B vitamins, magnesium, vitamin D, zinc, and probiotics. Results: Prospective evidence generally linked higher diet quality with lower depression risk. Whole-diet intervention trials showed mixed results, with several studies reporting improvements in depressive outcomes; anxiety outcomes were less consistent. Mechanistic literature supports plausibility through inflammation/oxidative pathways, serotonergic neurotransmission, and diet–microbiota interactions. Among supplements, evidence is most developed for omega-3 fatty acids (dose-response signals for anxiety) and magnesium (benefits in trials and meta-analysis), while findings for vitamin D, B vitamins, zinc and probiotics vary across studies. Conclusions: Diet quality improvement and selected supplements may offer adjunctive benefits for some individuals, but effects are heterogeneous and should not be overgeneralised. Nutritional strategies should be integrated with evidence-based mental health care, with timely clinical assessment and standard treatments used when indicated.
- Open Access
- 13 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 87, 68133
Hashimoto’s Thyroiditis: An Overview of Current Evidence from the Literature
Introduction and purpose Hashimoto’s thyroiditis is the most prevalent autoimmune disorder of the thyroid and a primary cause of hypothyroidism. It occurs predominantly in women and often manifests with vague, nonspecific complaints, which may also be present in euthyroid patients, leading to delayed recognition. Although levothyroxine remains the cornerstone of therapy, a subset of patients continues to report ongoing symptoms. This review outlines current evidence regarding the epidemiology, pathophysiology, clinical presentation, diagnostic approach, and both established and emerging therapeutic options for this condition. A brief description of the state of knowledgeHashimoto’s thyroiditis is a frequent autoimmune disease and the leading cause of hypothyroidism in many populations. Its pathogenesis involves an interplay of genetic predisposition, environmental factors, and dysregulation of the immune response. Clinical manifestations are heterogeneous and may include fatigue, depressive symptoms, and cognitive difficulties, even in the presence of normal thyroid hormone levels. Diagnosis is based on clinical evaluation supported by laboratory assessment of thyroid hormones and antibodies, as well as ultrasound imaging. While levothyroxine effectively normalizes biochemical parameters in most cases, persistent symptoms are commonly reported. This has led to growing interest in adjunctive interventions such as selenium, vitamin D, and inositol supplementation, acupuncture, and lifestyle modification. Increasing attention is also being paid to the influence of the gut–thyroid axis, including the potential role of probiotics in immune modulation. An individualized and more comprehensive treatment strategy may benefit patients with an incomplete response to standard therapy. ConclusionsHashimoto’s thyroiditis is a multifactorial autoimmune condition that often necessitates an individualized therapeutic approach. Persistent symptoms despite appropriate treatment are common. Integrating conventional management with supportive measures may enhance clinical outcomes and improve patients’ quality of life.
- 13 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 87, 68133
Open AccessHashimoto’s Thyroiditis: An Overview of Current Evidence from the Literature
Introduction and purpose Hashimoto’s thyroiditis is the most prevalent autoimmune disorder of the thyroid and a primary cause of hypothyroidism. It occurs predominantly in women and often manifests with vague, nonspecific complaints, which may also be present in euthyroid patients, leading to delayed recognition. Although levothyroxine remains the cornerstone of therapy, a subset of patients continues to report ongoing symptoms. This review outlines current evidence regarding the epidemiology, pathophysiology, clinical presentation, diagnostic approach, and both established and emerging therapeutic options for this condition. A brief description of the state of knowledgeHashimoto’s thyroiditis is a frequent autoimmune disease and the leading cause of hypothyroidism in many populations. Its pathogenesis involves an interplay of genetic predisposition, environmental factors, and dysregulation of the immune response. Clinical manifestations are heterogeneous and may include fatigue, depressive symptoms, and cognitive difficulties, even in the presence of normal thyroid hormone levels. Diagnosis is based on clinical evaluation supported by laboratory assessment of thyroid hormones and antibodies, as well as ultrasound imaging. While levothyroxine effectively normalizes biochemical parameters in most cases, persistent symptoms are commonly reported. This has led to growing interest in adjunctive interventions such as selenium, vitamin D, and inositol supplementation, acupuncture, and lifestyle modification. Increasing attention is also being paid to the influence of the gut–thyroid axis, including the potential role of probiotics in immune modulation. An individualized and more comprehensive treatment strategy may benefit patients with an incomplete response to standard therapy. ConclusionsHashimoto’s thyroiditis is a multifactorial autoimmune condition that often necessitates an individualized therapeutic approach. Persistent symptoms despite appropriate treatment are common. Integrating conventional management with supportive measures may enhance clinical outcomes and improve patients’ quality of life.
- Open Access
- 31 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 51, 68181
Topical niacinamide in the management of melasma and facial hyperpigmentation – a narrative review
Background: Melasma is a common facial hyperpigmentation condition and has an impact on patients’ quality of life. This and other facial hyperpigmentation disorders are common problems in women of reproductive age. The standard of care remains topical hydroquinone, often combined with a retinoid and a corticosteroid. However, its long-term use is associated with a risk of irritation, paradoxical hypopigmentation and exogenous ochronosis. Niacinamide is a well-established dermocosmetic ingredient with anti-inflammatory, antioxidant, barrier-protective and depigmenting properties. Aim: To summarise current knowledge on the mechanisms of action of niacinamide in the regulation of skin pigmentation and to review clinical studies on topical niacinamide in melasma and other facial hyperpigmentation disorders. Material and methods: A review of the literature was conducted in PubMed, PubMed Central and Google Scholar from 2015 to 2025. The articles were included if they were full-text original reviews and addressed topical niacinamide use. Results: Topical 4% niacinamide demonstrated efficacy comparable to 4% hydroquinone. The advantages are better tolerability, less erythema and dryness, and no reports of ochronosis. Niacinamide acts mainly by inhibiting melanosome transfer, modulating oxidative stress and the inflammatory response. Combinations of niacinamide with other depigmenting agents and procedural interventions, like laser therapy, microneedling or chemical peels, were effective in melasma, post-inflammatory acne hyperpigmentation, and photoaging. It is a safe alternative to hydroquinone-containing preparations. Conclusions: Topical niacinamide is a safe and versatile depigmenting agent with a pleiotropic mechanism of action. It should be considered an important component of modern treatment algorithms for facial hyperpigmentation, both as an alternative to hydroquinone and as a key element of combination and maintenance regimens.
- 31 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 51, 68181
Open AccessTopical niacinamide in the management of melasma and facial hyperpigmentation – a narrative review
Background: Melasma is a common facial hyperpigmentation condition and has an impact on patients’ quality of life. This and other facial hyperpigmentation disorders are common problems in women of reproductive age. The standard of care remains topical hydroquinone, often combined with a retinoid and a corticosteroid. However, its long-term use is associated with a risk of irritation, paradoxical hypopigmentation and exogenous ochronosis. Niacinamide is a well-established dermocosmetic ingredient with anti-inflammatory, antioxidant, barrier-protective and depigmenting properties. Aim: To summarise current knowledge on the mechanisms of action of niacinamide in the regulation of skin pigmentation and to review clinical studies on topical niacinamide in melasma and other facial hyperpigmentation disorders. Material and methods: A review of the literature was conducted in PubMed, PubMed Central and Google Scholar from 2015 to 2025. The articles were included if they were full-text original reviews and addressed topical niacinamide use. Results: Topical 4% niacinamide demonstrated efficacy comparable to 4% hydroquinone. The advantages are better tolerability, less erythema and dryness, and no reports of ochronosis. Niacinamide acts mainly by inhibiting melanosome transfer, modulating oxidative stress and the inflammatory response. Combinations of niacinamide with other depigmenting agents and procedural interventions, like laser therapy, microneedling or chemical peels, were effective in melasma, post-inflammatory acne hyperpigmentation, and photoaging. It is a safe alternative to hydroquinone-containing preparations. Conclusions: Topical niacinamide is a safe and versatile depigmenting agent with a pleiotropic mechanism of action. It should be considered an important component of modern treatment algorithms for facial hyperpigmentation, both as an alternative to hydroquinone and as a key element of combination and maintenance regimens.
- Open Access
- 27 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50
The Role of Yoga in Cardiovascular Prevention and Rehabilitation - A Structured Narrative Review
Background: Yoga is increasingly used as an adjunct mind–body intervention in cardiovascular prevention and rehabilitation, with proposed effects on stress regulation and autonomic balance. Aim: To summarize evidence on yoga-based interventions in cardiovascular disease and cardiac rehabilitation, focusing on clinical outcomes, patient-reported outcomes, and autonomic function. Material and methods: A focused narrative review of clinical trials and evidence syntheses evaluating yoga in coronary heart disease/post–myocardial infarction settings, arrhythmias, and chronic heart failure was performed. Evidence was synthesized qualitatively and grouped by clinical condition and outcome domain. Results: In paroxysmal atrial fibrillation, yoga interventions have been associated with reductions in arrhythmia burden and improvements in anxiety, depression, and quality of life in controlled studies. In coronary heart disease and secondary prevention, systematic reviews suggest improvements in selected cardiovascular risk factors and patient-centered outcomes, although confidence is limited by heterogeneity in yoga protocols, comparators, and endpoints. In post–myocardial infarction cardiac rehabilitation, randomized trials report feasibility of structured delivery and improvements in rehabilitation-related and psychosocial outcomes. In chronic heart failure, clinical studies and meta-analytic evidence indicate favorable changes in hemodynamic measures and autonomic indices, including heart rate variability. Conclusions: Yoga may offer adjunctive benefits for quality of life, psychological outcomes, autonomic function, and selected physiological measures, while evidence for hard clinical endpoints remains limited. Larger, standardized randomized trials with consistent outcome reporting are needed.
- 27 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50
Open AccessThe Role of Yoga in Cardiovascular Prevention and Rehabilitation - A Structured Narrative Review
Background: Yoga is increasingly used as an adjunct mind–body intervention in cardiovascular prevention and rehabilitation, with proposed effects on stress regulation and autonomic balance. Aim: To summarize evidence on yoga-based interventions in cardiovascular disease and cardiac rehabilitation, focusing on clinical outcomes, patient-reported outcomes, and autonomic function. Material and methods: A focused narrative review of clinical trials and evidence syntheses evaluating yoga in coronary heart disease/post–myocardial infarction settings, arrhythmias, and chronic heart failure was performed. Evidence was synthesized qualitatively and grouped by clinical condition and outcome domain. Results: In paroxysmal atrial fibrillation, yoga interventions have been associated with reductions in arrhythmia burden and improvements in anxiety, depression, and quality of life in controlled studies. In coronary heart disease and secondary prevention, systematic reviews suggest improvements in selected cardiovascular risk factors and patient-centered outcomes, although confidence is limited by heterogeneity in yoga protocols, comparators, and endpoints. In post–myocardial infarction cardiac rehabilitation, randomized trials report feasibility of structured delivery and improvements in rehabilitation-related and psychosocial outcomes. In chronic heart failure, clinical studies and meta-analytic evidence indicate favorable changes in hemodynamic measures and autonomic indices, including heart rate variability. Conclusions: Yoga may offer adjunctive benefits for quality of life, psychological outcomes, autonomic function, and selected physiological measures, while evidence for hard clinical endpoints remains limited. Larger, standardized randomized trials with consistent outcome reporting are needed.
- Open Access
- 3 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49
The impact of obesity on clinical outcomes in acute pancreatitis: a systematic review
Background: Obesity may influence the severity of acute pancreatitis (AP) by intensifying inflammatory and metabolic disturbances. However, evidence is inconsistent due to differences in patient characteristics and AP causes. Clarification is needed to determine if obesity reliably predicts severe AP and complications. Aim:To evaluate the association between obesity, disease severity, complications, and clinical outcomes in AP. Methods: We conducted a systematic review of observational studies following PRISMA guidelines. We searched databases for studies on adult AP patients assessing obesity or BMI in relation to disease severity, organ failure, local complications, ICU admission, or mortality. We excluded studies on visceral adiposity indices only, pediatric cohorts, non-original publications, and non-RCT/non-observational designs. Results: Eleven studies met the inclusion criteria. Most reported that obesity is linked with increased AP severity and higher rates of systemic or local complications, such as organ failure, necrosis, and greater healthcare utilization. Large database studies confirmed increased complication rates in obese patients. However, findings regarding mortality were inconsistent: some studies noted higher mortality in overweight individuals, others showed no difference. Studies using BMI as a continuous variable found a consistent association between higher BMI and increased AP severity. Conclusions: Obesity appears to be associated with more severe AP and selected complications, but its link to mortality remains unclear. BMI alone shows limited predictive value and should be interpreted alongside other clinical data. Further research is required to standardize the incorporation of obesity into early AP risk assessment.
- 3 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49
Open AccessThe impact of obesity on clinical outcomes in acute pancreatitis: a systematic review
Background: Obesity may influence the severity of acute pancreatitis (AP) by intensifying inflammatory and metabolic disturbances. However, evidence is inconsistent due to differences in patient characteristics and AP causes. Clarification is needed to determine if obesity reliably predicts severe AP and complications. Aim:To evaluate the association between obesity, disease severity, complications, and clinical outcomes in AP. Methods: We conducted a systematic review of observational studies following PRISMA guidelines. We searched databases for studies on adult AP patients assessing obesity or BMI in relation to disease severity, organ failure, local complications, ICU admission, or mortality. We excluded studies on visceral adiposity indices only, pediatric cohorts, non-original publications, and non-RCT/non-observational designs. Results: Eleven studies met the inclusion criteria. Most reported that obesity is linked with increased AP severity and higher rates of systemic or local complications, such as organ failure, necrosis, and greater healthcare utilization. Large database studies confirmed increased complication rates in obese patients. However, findings regarding mortality were inconsistent: some studies noted higher mortality in overweight individuals, others showed no difference. Studies using BMI as a continuous variable found a consistent association between higher BMI and increased AP severity. Conclusions: Obesity appears to be associated with more severe AP and selected complications, but its link to mortality remains unclear. BMI alone shows limited predictive value and should be interpreted alongside other clinical data. Further research is required to standardize the incorporation of obesity into early AP risk assessment.
- Open Access
- 3 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49
The impact of obesity on clinical outcomes in acute pancreatitis: a systematic review
Background: Obesity may influence the severity of acute pancreatitis (AP) by intensifying inflammatory and metabolic disturbances. However, evidence is inconsistent due to differences in patient characteristics and AP causes. Clarification is needed to determine if obesity reliably predicts severe AP and complications. Aim:To evaluate the association between obesity, disease severity, complications, and clinical outcomes in AP. Methods: We conducted a systematic review of observational studies following PRISMA guidelines. We searched databases for studies on adult AP patients assessing obesity or BMI in relation to disease severity, organ failure, local complications, ICU admission, or mortality. We excluded studies on visceral adiposity indices only, pediatric cohorts, non-original publications, and non-RCT/non-observational designs. Results: Eleven studies met the inclusion criteria. Most reported that obesity is linked with increased AP severity and higher rates of systemic or local complications, such as organ failure, necrosis, and greater healthcare utilization. Large database studies confirmed increased complication rates in obese patients. However, findings regarding mortality were inconsistent: some studies noted higher mortality in overweight individuals, others showed no difference. Studies using BMI as a continuous variable found a consistent association between higher BMI and increased AP severity. Conclusions: Obesity appears to be associated with more severe AP and selected complications, but its link to mortality remains unclear. BMI alone shows limited predictive value and should be interpreted alongside other clinical data. Further research is required to standardize the incorporation of obesity into early AP risk assessment.
- 3 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49
Open AccessThe impact of obesity on clinical outcomes in acute pancreatitis: a systematic review
Background: Obesity may influence the severity of acute pancreatitis (AP) by intensifying inflammatory and metabolic disturbances. However, evidence is inconsistent due to differences in patient characteristics and AP causes. Clarification is needed to determine if obesity reliably predicts severe AP and complications. Aim:To evaluate the association between obesity, disease severity, complications, and clinical outcomes in AP. Methods: We conducted a systematic review of observational studies following PRISMA guidelines. We searched databases for studies on adult AP patients assessing obesity or BMI in relation to disease severity, organ failure, local complications, ICU admission, or mortality. We excluded studies on visceral adiposity indices only, pediatric cohorts, non-original publications, and non-RCT/non-observational designs. Results: Eleven studies met the inclusion criteria. Most reported that obesity is linked with increased AP severity and higher rates of systemic or local complications, such as organ failure, necrosis, and greater healthcare utilization. Large database studies confirmed increased complication rates in obese patients. However, findings regarding mortality were inconsistent: some studies noted higher mortality in overweight individuals, others showed no difference. Studies using BMI as a continuous variable found a consistent association between higher BMI and increased AP severity. Conclusions: Obesity appears to be associated with more severe AP and selected complications, but its link to mortality remains unclear. BMI alone shows limited predictive value and should be interpreted alongside other clinical data. Further research is required to standardize the incorporation of obesity into early AP risk assessment.
- Open Access
- 6 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 47
Rhinitis in Swimmers: A Clinical Issue at the Intersection of Sports Medicine and Otorhinolaryngology
The development of rhinitis in swimmers is multifactorial. Contact with disinfection byproducts plays a role in the pathogenesis of swimmer's rhinitis, leading to irritation, increased epithelial permeability, and the development of mucosal hyperreactivity, which promotes the dominance of the non-allergic irritant rhinitis phenotype in competitive swimmers. A significant deterioration in quality of life has been demonstrated in swimmers with rhinitis, as assessed using validated scales, in particular the miniRQLQ. The review emphasises the role of chronic exposure to the swimming pool environment as a modifiable risk factor and indicates that limiting contact with irritants – through the use of swimming clips, optimising ventilation, and improving water quality – can lead to reduced symptom severity and partial reversibility of changes in the nasal mucosa. Attention was drawn to the significant heterogeneity in definitions and diagnostic criteria in the literature, which makes it difficult to assess the disease's prevalence and mechanisms clearly.
- 6 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 47
Open AccessRhinitis in Swimmers: A Clinical Issue at the Intersection of Sports Medicine and Otorhinolaryngology
The development of rhinitis in swimmers is multifactorial. Contact with disinfection byproducts plays a role in the pathogenesis of swimmer's rhinitis, leading to irritation, increased epithelial permeability, and the development of mucosal hyperreactivity, which promotes the dominance of the non-allergic irritant rhinitis phenotype in competitive swimmers. A significant deterioration in quality of life has been demonstrated in swimmers with rhinitis, as assessed using validated scales, in particular the miniRQLQ. The review emphasises the role of chronic exposure to the swimming pool environment as a modifiable risk factor and indicates that limiting contact with irritants – through the use of swimming clips, optimising ventilation, and improving water quality – can lead to reduced symptom severity and partial reversibility of changes in the nasal mucosa. Attention was drawn to the significant heterogeneity in definitions and diagnostic criteria in the literature, which makes it difficult to assess the disease's prevalence and mechanisms clearly.